RecruitingNot ApplicableNCT06152302

Test of Aquatic Mobility of SMA Infants

Analysis of Mobility in the Bath for Infants Affected With Spinal Muscular Atrophy


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

15 participants

Start Date

Jun 26, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Spinal muscular atrophy (SMA) is a genetic neurodegenerative disease impacting spinal cord motor neurons, leading to motor and respiratory issues and, ultimately, death. With emerging therapies, a need arises to enhance motor function assessment in severely hypotonic infants (SMA type 1) as traditional scales on examination tables lack completeness due to gravity's influence. The study team has developed a "bath test" to observe infants' motor skills in water, eliminating gravity's effects. This test aims to detect subtle movements using inertial sensors, potentially revealing more active motor neurons in aquatic conditions. It aids in identifying infants with motor improvement potential, even if they show limited mobility outside water, and tracks disease progression and therapy responses. Presently, pediatric neurologists in France use parent-provided bathing videos for evaluations, but these lack standardization and precision. The study aims to establish a standardized evaluation protocol with quantifiable data. The study's key objective is to evaluate severely hypotonic SMA infants using inertial sensors, including accelerometers, gyrometers, and magnetometers. The study will conduct "dry" and "water" assessments using a specially designed bathtub. This method's goal is to quantify water-based movements accurately. Simultaneously, the study seeks to establish semi-quantitative evaluation criteria to create a clinical assessment scale for infant motor function in bathtubs. This scale will aid doctors in therapeutic decisions. The study will not influence the treatment or therapeutic decisions made for the children being tested. Collected data from "dry" and "water" conditions will be statistically analyzed and compared to reference motor assessment scales (e.g., CHOP INTEND and HINE) and electromyography (CMAP-EMG) results, commonly used in diagnosis and monitoring. Blurred video recordings will assist in protocol monitoring and sensor data analysis.


Eligibility

Max Age: 12 Months

Inclusion Criteria6

  • Infants with muscle weakness (commonly referred to as floppy babies):
  • Confirmed diagnosis of SMA through gene mutation or deletion (SMN1 gene).
  • Receiving standard care.
  • Age less than 12 years and a height of less than 90 cm at the time of inclusion.
  • Patients enrolled in a social security scheme.
  • Informed consent signed by both parents of the child and the investigator.

Exclusion Criteria2

  • Patients presenting with lesions in the spinal cord or conditions affecting the cardiorespiratory system.
  • Patients covered under the French Aid in Health for Foreign People program (AME).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMobility study in dry conditions

Record the movements of the baby's extremities using inertial sensors while the baby moves outside of the water.

OTHERMobility study in water conditions

Record the movements of the baby's extremities using inertial sensors while the baby moves inside the water.


Locations(1)

Infantile neuromuscular unity - Department of paediatric neurological care and intentive care unity, Raymond Poincaré Hospital - APHP

Garches, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06152302


Related Trials